Research News and Research

RSS

Two papers highlight therapeutic potential of human Sertoli cells

Two papers published in the current issue of Cell Transplantation, now freely available on-line at http://www.ingentaconnect.com/content/cog/ct/, highlight the therapeutic potential of human Sertoli cells that are present in the testes and are also called "nurse" or "mother" cells because they nurture the developing sperm cells.

12 Jul 2011

Cancer Cell publishes results of melanoma study

Metamark Genetics, Inc., a privately-held oncology-focused molecular diagnostics company, today announced results from a melanoma study published in Cancer Cell.

12 Jul 2011

KiDA to host Third Annual Summit on Autism

Kids Institute for Development and Advancement (KiDA), a premier center for autism treatment, hosts its Third Annual Summit on Autism Saturday, September 17, 2011, at the University of California, Irvine's Bren Events Center, beginning at 8:00 am.

12 Jul 2011

Poisonous shrub extract may act as natural painkiller

An extract of the poisonous shrub Jatropha curcas acts as a strong painkiller and may have a mode of action different from conventional analgesics, such as morphine and other pharmaceuticals.

12 Jul 2011

IGR, IPSEN sign 3 year medical oncology agreement

IPSEN, a global biopharmaceutical company represented by Claude Bertrand, Executive Vice President, R&D and Chief Scientific Officer, and Institut de cancérologie Gustave Roussy, a leading international cancer center represented by Professor Alexander Eggermont, General Director, today announced the signature of a partnership in the area of medical oncology to leverage the combined expertises of their respective R&D teams.

12 Jul 2011

Groundbreaking study on treatment of separation anxiety disorder

A group of Swiss researchers headed by Prof. Sylvia Schneider has published a groundbreaking study on treatment of separation anxiety in the current issue of Psychotherapy and Psychosomatics.

12 Jul 2011

Factors leading to drought are varied

In addition to "ecological factors," "long and recurrent conflicts, poor infrastructure, misguided policy options, weak market system and seasonal migration patterns account to the ever-increasing drought problems" in the Horn of Africa, Abeje Chumo, an international law expert and editor of the Horn of Africa blog for the Foreign Policy Association, writes in a post on the Foreign Policy Blogs Network.

12 Jul 2011

genOway acquires worldwide exclusive license for RMCE technology from bluebird bio for genetically modified rodents

genOway and bluebird bio report today genOway acquisition of an exclusive worldwide license for the RMCE technology (developed at the Massachusetts Institute of Technology) in the field of genetically modified rodents.

12 Jul 2011

Study may help explain why antipsychotic drugs can promote overeating, weight gain

Research to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, may explain why some antipsychotic drugs can promote overeating, weight gain, and insulin resistance.

12 Jul 2011

Obesity epidemic in teens and young adults began to rise in late 1990s

A new study that looks at weight change over decades finds that the obesity epidemic in teens and young adults has its roots in the late 1990s and early 2000s, when body weights began to rise. But not everyone was affected equally.

12 Jul 2011

Molasses supplementation may reduce obesity in humans

Experimental results to be presented at the upcoming annual meeting of the Society for the Study of Ingestive Behavior (SSIB), the foremost society for research into all aspects of eating and drinking behavior, suggests that dietary supplementation with molasses extract may provide a novel approach for weight management in humans.

12 Jul 2011

AACR Conference on Frontiers in Basic Cancer Research to be held in San Francisco

For more than 100 years, the American Association for Cancer Research has been the premier leader in the basic science of cancer research.

12 Jul 2011

FDA approves protocol for Medtronic's SYMPLICITY HTN-3 for treatment of hypertension

Medtronic, Inc., announced today that the U.S. Food and Drug Administration (FDA) has conditionally approved the protocol for SYMPLICITY HTN-3, the company's U.S. clinical trial of renal denervation with the Symplicity Catheter System for the treatment of resistant hypertension, an especially dangerous disease affecting hundreds of millions of people worldwide.

From Medtronic 12 Jul 2011

Hutchinson Center receives $20M NIH grant to eradicate HIV infection

Whether a stem cell transplant using an HIV-infected person's own genetically modified immune cells can become a cure for the disease is the focus of a new $20 million, five-year research grant award announced today by the National Institutes of Health to Fred Hutchinson Cancer Research Center.

12 Jul 2011

Maternal smoking during pregnancy causes serious birth defects

To dispel any uncertainty about the serious harm caused by smoking to babies and pregnant women, the first-ever comprehensive systematic review of all studies over the past 50 years has established clearly that maternal smoking causes a range of serious birth defects including heart defects, missing/deformed limbs, clubfoot, gastrointestinal disorders, and facial disorders.

12 Jul 2011

Cancer Cell publishes Epizyme and collaborators' breakthrough research on MLL

Epizyme, Inc., a company leading the discovery and development of personalized therapeutics for genetically-defined cancer and rare disease patients, and its collaborators announced the publication in Cancer Cell of breakthrough research in the treatment of MLL-rearranged leukemia (MLL), a genetically-defined subset of acute lymphoblastic leukemia and acute myelogenous leukemia.

12 Jul 2011

Scientists to receive prestigious awards for innovative HIV research at IAS 2011

The International AIDS Society (IAS) announced today the six winners of three prestigious scientific awards, to be presented at plenary sessions during the 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention to be held in Rome July 17-20, 2011.

12 Jul 2011